Beta Bionics, Inc. Common Stock BBNX Ratios & Valuation
| Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | ||
|---|---|---|---|---|---|---|
| Profitability | ||||||
| Gross margin | 57.2%+3.2pp | 55.4%+0.3pp | 54.5%+0.5pp | 53.9%-0.3pp | 53.9%-0.5pp | |
| Operating margin | -70.1%+7.8pp | -71.5%-2.0pp | -77.4%+8.9pp | -80.1%+35.1pp | -78%+87.8pp | |
| Net margin | -60.3%+41.4pp | -73%+11.1pp | -87.9%+12.1pp | -94%+50.1pp | -101.6%+106pp | |
| EBITDA margin | -68.4%+7.8pp | -69.9%-2.2pp | -76%+7.8pp | -78.6%+33.1pp | -76.3%+83.9pp | |
| Free cash flow margin | -55.4%+29.7pp | -56.1%+23.3pp | -68.3%+26.1pp | -79.5%+43.2pp | -85.1%+84.5pp | |
| Returns | ||||||
| Return on equity | -22.7%— | —— | —— | —— | —— | |
| Return on assets | -20.7%— | -30.6%+11.6pp | —— | —— | —— | |
| Return on invested capital | -29.4%— | —— | —— | —— | —— | |
| Efficiency | ||||||
| Asset turnover | 0.3×— | 0.4×-0.1× | —— | —— | —— | |
| Inventory turnover | 2.4×-1.2× | 2.6×-1.5× | 3.3×-7.1× | 3.4×-4.0× | 3.5×-3.8× | |
| Liquidity | ||||||
| Current ratio | 10.7×-5.2× | 8.7×+2.4× | 10.6×— | 14.7×— | 15.9×— | |
| Quick ratio | 9.7×-5.3× | 8×+2.3× | 9.8×— | 13.8×— | 14.9×— | |
| Cash ratio | 1.3×-1.3× | 1×-0.4× | 1.5×— | 1.8×— | 2.6×— | |
| Leverage | ||||||
| Debt-to-equity | 0×0.0× | 0×— | 0×— | 0×— | 0×— | |
| Debt-to-assets | 0×0.0× | 0×0.0× | 0×— | 0×— | 0×— | |
| Per Share | ||||||
| Book value per share | $6.10-40.2% | $7.10+118% | $6.76+120% | $6.95+119% | $10.22+129% | |
| Valuation | ||||||
| Market capitalization | $708.98M-8.6% | $1.34B— | $863.75M— | $681.56M— | —— | |
| Enterprise value | $685.68M— | $1.32B— | $832.95M— | $653.17M— | —— | |
| Price / sales | 6.4×— | 13.4×— | 9.8×— | 8.7×— | —— | |
| Price / book | 2.6×— | 4.7×— | 2.9×— | 2.3×— | —— | |
| EV / sales | 6.2×— | 13.1×— | 9.4×— | 8.4×— | —— | |
| Free cash flow yield | -8.6%— | -4.2%— | -7%— | -9.1%— | —— | |
| Earnings yield | -9.4%— | -5.5%— | -9%— | -10.8%— | —— |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What are Beta Bionics, Inc. Common Stock's profit margins?
- Beta Bionics, Inc. Common Stock (BBNX) runs a 57.2% gross margin and a -70.1% operating margin, with a -60.3% net margin.
- Where do Beta Bionics, Inc. Common Stock's ratios come from?
- Every ratio is computed from Beta Bionics, Inc. Common Stock's SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.
